Logo image of OXBR

OXBRIDGE RE HOLDINGS LTD (OXBR) Stock Fundamental Analysis

NASDAQ:OXBR - Nasdaq - KYG6856M1069 - Common Stock - Currency: USD

5.14  -0.2 (-3.75%)

After market: 5 -0.14 (-2.72%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to OXBR. OXBR was compared to 144 industry peers in the Insurance industry. OXBR may be in some trouble as it scores bad on both profitability and health. OXBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OXBR had negative earnings in the past year.
OXBR had a negative operating cash flow in the past year.
OXBR had negative earnings in 4 of the past 5 years.
OXBR had a negative operating cash flow in each of the past 5 years.
OXBR Yearly Net Income VS EBIT VS OCF VS FCFOXBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

OXBR has a Return On Assets of -67.43%. This is amonst the worse of the industry: OXBR underperforms 97.87% of its industry peers.
OXBR has a worse Return On Equity (-135.25%) than 96.45% of its industry peers.
Industry RankSector Rank
ROA -67.43%
ROE -135.25%
ROIC N/A
ROA(3y)-27.49%
ROA(5y)-17.26%
ROE(3y)-48.81%
ROE(5y)-30.18%
ROIC(3y)N/A
ROIC(5y)N/A
OXBR Yearly ROA, ROE, ROICOXBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OXBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OXBR Yearly Profit, Operating, Gross MarginsOXBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

3

2. Health

2.1 Basic Checks

OXBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
OXBR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, OXBR has more shares outstanding
The debt/assets ratio for OXBR is higher compared to a year ago.
OXBR Yearly Shares OutstandingOXBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
OXBR Yearly Total Debt VS Total AssetsOXBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -0.07, we must say that OXBR is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of -0.07, OXBR is doing good in the industry, outperforming 68.79% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that OXBR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, OXBR belongs to the top of the industry, outperforming 88.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.07
ROIC/WACCN/A
WACC9.03%
OXBR Yearly LT Debt VS Equity VS FCFOXBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

OXBR has a Current Ratio of 0.13. This is a bad value and indicates that OXBR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OXBR (0.13) is better than 68.09% of its industry peers.
OXBR has a Quick Ratio of 0.13. This is a bad value and indicates that OXBR is not financially healthy enough and could expect problems in meeting its short term obligations.
OXBR has a Quick ratio of 0.13. This is in the better half of the industry: OXBR outperforms 68.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
OXBR Yearly Current Assets VS Current LiabilitesOXBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K

More info and screens

1

3. Growth

3.1 Past

OXBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.40%, which is quite impressive.
The Revenue has grown by 13.22% in the past year. This is quite good.
Measured over the past years, OXBR shows a very negative growth in Revenue. The Revenue has been decreasing by -13.51% on average per year.
EPS 1Y (TTM)25.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.74%
Revenue 1Y (TTM)13.22%
Revenue growth 3Y10.69%
Revenue growth 5Y-13.51%
Sales Q2Q%103.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OXBR Yearly Revenue VS EstimatesOXBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
OXBR Yearly EPS VS EstimatesOXBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OXBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OXBR Price Earnings VS Forward Price EarningsOXBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OXBR Per share dataOXBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OXBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OXBRIDGE RE HOLDINGS LTD

NASDAQ:OXBR (2/21/2025, 8:00:02 PM)

After market: 5 -0.14 (-2.72%)

5.14

-0.2 (-3.75%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-24 2025-03-24
Inst Owners8.01%
Inst Owner Change35.97%
Ins Owners9.24%
Ins Owner Change0%
Market Cap32.02M
Analysts0
Price TargetN/A
Short Float %0.95%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.3
P/FCF N/A
P/OCF N/A
P/B 8.77
P/tB 8.77
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.45
BVpS0.59
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.43%
ROE -135.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-27.49%
ROA(5y)-17.26%
ROE(3y)-48.81%
ROE(5y)-30.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -0.07
F-Score3
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.22%
Revenue growth 3Y10.69%
Revenue growth 5Y-13.51%
Sales Q2Q%103.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-193.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.49%
OCF growth 3YN/A
OCF growth 5YN/A